| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |